Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity

NANot yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
Liver SteatosisMASHMASLD
Interventions
BEHAVIORAL

Telehealth coaching for liver disease

"This study is an open-label, mono-centred, single-case experimental design with multiple base levels. The study will comprise 3 phases, alternating periods of observation (A) and 1 period of counselling (B) with an A1-B-A2 design.~PA will be assessed continuously using an accelerometer for 7 to 14 days per (A) phase. During phase (B), participants will receive the intervention, i.e. 6 x 45-minute, real-time, face-to-face, virtual sessions with a PA counsellor."

All Listed Sponsors
lead

Hopital Montfort

OTHER

NCT06446908 - Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity | Biotech Hunter | Biotech Hunter